3Yi NJ,Suh KS,Cho JY,et al.Recurrence of hepatitis B is associated with cumulative cortieosteroid dose and chemotherapy gainst hepatocellular carcinoma recurrence after liver transp|antation[J].Livvr Transpl,2007,13:451-458. 被引量：1
2Wozel G,Feiffer C.Leflunomide-a new drug for pharmacological immunomodulation[J].Hautarzt,2002,53(5):309-315. 被引量：1
3Maddisom P,Kiely P,Kirkham B,et al.Leflunomide in rheumatoid arthritis:recommendations through a process of consensus[J].Rheumatology (Oxford),2005,44(3):280-286. 被引量：1
5Tam LS,Li EK,Wong CK,et al.Safety and efficacy of leflunomide in the treatment of lupus nephritis refractory or intolerant to traditional immunosuppressive therapy:an open label trial[J].Ann Rheum Dis,2006,65(3):417-418. 被引量：1
6Lou T,Wang C,Chen Z,et al.Randomised controlled trial of leflunomide in the treatment of immunoglobulin A nephropathy[J].Nephrology,2006,11(2):113-116. 被引量：1
7Gulati S,Pokhariyal S,Sharma RK,et al.Pulse cyclophosphamide therapy in frequently relapsing nephritic syndrome[J].Nephrol Dial Trans Plant,2001,16(10):2 013-2 027. 被引量：1
